Investigation of the Serum Level of Vitamin D in Patients with Ear Cholesteatoma

Document Type : Original

Authors

Clinical Research Unit, Shafa Hospital, Kerman University of Medical Science, Kerman, Iran.

Abstract

Introduction:
This study aimed to investigate the serum level of vitamin D in patients with ear cholesteatoma.
 
Materials and Methods:
This cross-sectional study was performed on 62 patients with middle ear cholesteatoma (case group) and 62 patients with simple chronic otitis media (control group). Both groups had the same age (32±1 in the case group and 34±1 in the control group; P=0.973) and gender. Vitamin D serum level was measured in the two groups. Data analysis was conducted using t-test and ANOVA.
 
Results:
According to the statistical analysis, a significant relationship was observed between the serum level of vitamin D and middle ear cholesteatoma (P=0.000). The results showed that the serum level of vitamin D was lower in the case group, compared to the control group.
Conclusions:
Vitamin D serum level was lower in the cholesteatoma group. Moreover, it was strongly associated with hearing loss, tinnitus, and vertigo.

Keywords


  1. Tono T, Sakagami M, Kojima H, Hato N,Morita Y,Y, Matsuda K, Komori M, Hato N, Morita Y and Hashimoto Sh: Staging and classification criteria for middle ear cholesteatoma proposed by the Japan Otological Society. Auris Nasus Larynx 2017; 44: 135-140.
  2. Matsuda K, Tono T, Kojima H, Yamamoto Y, Sakagami M, Mishiro Y, Hinohira Y and Okuno T: Practicality analysis of the staging system proposed by the Japan Otological Society for acquired middle ear cholesteatoma: A multicenter study of 446 surgical cases in Japan. Auris Nasus Larynx 2018;45: 45-50.
  3. Rutkowska J, Özgirgin N and Olszewska E: Cholesteatoma definition and classification: A literature review. J Int Adv Otol 2017;13: 266-271.
  4. Suzuki H, Ikezaki S, Imazato K, Koizumi H, Ohbuchi T, Hohchi N and etal: Partial mastoid obliteration combined with soft-wall reconstruction for middle ear cholesteatoma. Ann Otol Rhinol Laryngol 2014;123: 571-575.
  5. Blanco P, González F, Holguín J and Guerra C: Surgical management of middle ear cholesteatoma and reconstruction at the same time. Colomb Med (Cali) 2014; 45: 127-131.
  6. Zhu Z, Hong Y, Wang Y, He G and Ye S: The signifi cance of keratinocyte in hyperproliferation of middle ear cholesteatoma. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2016;30: 139-143, (In Chinese).
  7. Akkari M, Gabrillargues J, Saroul N, Pereira B, Russier M, Mom T and Gilain L: Contribution of magnetic resonance imaging to the diagnosis of middle ear cholesteatoma: Analysis of a series of 97 cases. Eur Ann Otorhinolaryngol Head Neck Dis 2014;131: 153-158.
  8. Arnson Y, Amital H, Shoenfeld Y. Vitamin D and autoimmunity: new etiological and therapeutic considerations. Ann Rheum Dis. 2007; 66:1137-42.
  9. Mckenna MJ. Differences in vitamin D status between countries in young adults and elderly. Am J Med.1992;93(1);69-77
  10. Lips P. Vitamin D status and nutrition in Europe and Asia. J Steroid Biochem Mol Biol.2007;103(3-5): 620-5.
  11. Chan TY. Seasonal variations in vitamin D statues and the incidence of tuberculosis in different countries. Respiration 1999;66(2):196.
  12. Zhang R, Naughton DP. Vitamin D in health and disease: current perspectives. Nutr J.2010;9: 65. doi:10.1186/1475-2891-9-65.
  13. Muhe L, Lulseged S, Mason KE, Simoes EA. Case-control study of the role of nutritional rickets in         the risk of developing pneumonia in Ethiopian children. Lancet. 1997; 349:1801–1804. doi: 10. 1016/S0140-6736(96)12098-5.
  14. Wayse W, Yousafzai A, Mogale K, Filteau S. Association of subclinical dihydroxivitamin vitamin D deficiency with severe acute lower respiratory tract infections in Indian children under 5 years. Eur J Clin Nutr. 2004; 58:563– 567.
  15. Bikle DD. vitamin D and the immune system: role in protection against bacterial infection. Curropin Nephrol Hypertens 2008; 17:348-52.
  16. Yung M, Tono T, Olszewska E, Yamamoto Y, Sudhoff H, Sakagami M, and etal al: EAONO/JOS joint consensus statements on the definitions, classification and staging of middle ear cholesteatoma. J Int Adv Otol 2017;13: 1-8.
  17. Rutkowska J, Özgirgin N and Olszewska E: Cholesteatoma definition and classification: A literature review. J Int Adv Otol 2017;13(2): 266-271.
  18. Mayer B. Biosynthesis and action of nitric oxide inmammalian TrendsBiochem. Sci.1997; 22: 477-481.

 

  1. Seo Hwa K, Baek MS, Sik Yoon D. Vitamin D Inhibits Expression and Activity of Matrix Metalloproteinase in Human Lung Fibroblasts (HFL-1) Cells. Tuberc Respir Dis 2014; 77:73-80.
  2. Schmid Mt, Grünsfelder P · Florian Hoppe Up-regulation of matrix metalloprotease-9 in middle ear cholesteatoma correlations with growth factor expression in vivo? Eur Arch Otorhinolaryngol 2001; 258:472–476.
  3. Kobayashi H,* Asano K,  Kanai K, and Suzaki Suppressive activity of vitamin D3 on matrix metalloproteinase production from cholesteatoma keratinocytes in vitro. Mediators of inflamation. 2005;2005(4):210-
  4. Clark JG. Uses and abuses of hearing loss classification. Asha. 1981 Jul 1;23(7):493-500
  5. Dawes P , Cruickshanks K , Marsden A, David R. Moore and Kevin J. Munro: Relationship Between Diet, Tinnitus, and Hearing Difficulties. Ear and Hearing ,the Official Journal of the American Auditory Society. 2020;41(2):289-299 .
  6. Karaer I , Akalın Y: Low vitamin B12 level and vitamin D level adversely effect on cochlear health in women . International Journal for Vitamin and Nutrition Research 2020;90:333-388.
  7. Algani M ,  Mirza A . Althobaiti A, AL-Nemmari H ,  Bakhsh Association of benign paroxysmal positional vertigo with vitamin D deficiency: a systematic review and meta-analysis. European Archives of Oto-Rhino-laryngology  2018; 275: 2705–2711.
  8. Ding J, Liu L, Kong WK, Chen XB, Liu X. Serum levels of 25-hydroxy vitamin D correlate with idiopathic benign paroxysmal positional vertigo. Bioscience reports. 2019 Apr 30;39(4).